Abstract
Paliperidone is an antipsychotic recently made available in the US and UK in a special oral extended release form. Paliperidone is a modified form of risperidone namely 9-hydroxyrisperidone, (itself the active metabolite of risperidone). Since risperidone has been available for many years some argue that paliperidone is not a novel antipsychotic but a newly marketed variant. An injectable form, paliperidone palmitate is being trialled. Paliperidone is mainly excreted renally and there is only limited hepatic metabolism. Paliperidone works by partially blocking D2 dopamine receptors and fully blocking serotonin. The normal dosing range for paliperidone is 3-12 mg daily. Efficacy studies with paliperidone indicate that it is effective against schizophrenia and also has a similar side effect profile compared to other antipsychotics. There is an absence of effects on glucose and lipids in comparison with olanzapine. Symptom reduction in schizophrenia occurs as soon as day four of treatment with paliperidone. Clinical experience with risperidone over many years suggests that paliperidone would have a valuable role as an antipsychotic. The entity is not truly novel, but rather than being a variant existing purely for marketing purposes, should be regarded as an upgrade.
Keywords: Paliperidone, antipsychotic, active metabolite, Clinical Review, hepatic metabolism, serotonin, schizophrenia
Current Drug Therapy
Title: Paliperidone: A Clinical Review
Volume: 4 Issue: 1
Author(s): Ben Green
Affiliation:
Keywords: Paliperidone, antipsychotic, active metabolite, Clinical Review, hepatic metabolism, serotonin, schizophrenia
Abstract: Paliperidone is an antipsychotic recently made available in the US and UK in a special oral extended release form. Paliperidone is a modified form of risperidone namely 9-hydroxyrisperidone, (itself the active metabolite of risperidone). Since risperidone has been available for many years some argue that paliperidone is not a novel antipsychotic but a newly marketed variant. An injectable form, paliperidone palmitate is being trialled. Paliperidone is mainly excreted renally and there is only limited hepatic metabolism. Paliperidone works by partially blocking D2 dopamine receptors and fully blocking serotonin. The normal dosing range for paliperidone is 3-12 mg daily. Efficacy studies with paliperidone indicate that it is effective against schizophrenia and also has a similar side effect profile compared to other antipsychotics. There is an absence of effects on glucose and lipids in comparison with olanzapine. Symptom reduction in schizophrenia occurs as soon as day four of treatment with paliperidone. Clinical experience with risperidone over many years suggests that paliperidone would have a valuable role as an antipsychotic. The entity is not truly novel, but rather than being a variant existing purely for marketing purposes, should be regarded as an upgrade.
Export Options
About this article
Cite this article as:
Green Ben, Paliperidone: A Clinical Review, Current Drug Therapy 2009; 4 (1) . https://dx.doi.org/10.2174/157488509787081903
DOI https://dx.doi.org/10.2174/157488509787081903 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lamotrigine Induced Whole Body Tics: A Case Report and Literature Review
Current Drug Safety Interplay between Epigenetics & Cancer Metabolism
Current Pharmaceutical Design Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Impulse Control Disorders in Parkinson’s Disease: A Review
Current Psychiatry Reviews Sleep, Depression and Insomnia – A Vicious Circle?
Current Psychiatry Reviews Multi- and Inter-Disciplinary Science in Personalized Delivery of Stem Cells for Tissue Repair
Current Stem Cell Research & Therapy Overlap between ADHD and Autism - Clinical and Genetic Evidence
Current Psychiatry Reviews Clearance of Amyloid-β Peptide Across the Choroid Plexus in Alzheimer's Disease
Current Aging Science Progress and Prospects of Chitosan and Its Derivatives as Non-Viral Gene Vectors in Gene Therapy
Current Gene Therapy Homology Modeling of Adenosine A2A Receptor and Molecular Docking for Exploration of Appropriate Potent Antagonists for Treatment of Parkinsons Disease
Current Aging Science Pharmacological Support of Neurorehabilitation
Current Drug Therapy Patents and the Development on Polymer based Nanomaterial (PAMAM Dendrimer) for Biomedical Applications
Recent Patents on Biomedical Engineering (Discontinued) Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer`s and Parkinson`s Diseases
Mini-Reviews in Medicinal Chemistry The Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity
Current Drug Metabolism Physical Activity and Sport in Advanced Age: Is it Risky? – A Summary of Data from Articles Published Between 2000-2009
Current Aging Science Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal and Human Studies
Current Pharmaceutical Design Multimodality Imaging in Acute Ischemic Stroke
Current Medical Imaging Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Current Hypertension Reviews MRI Techniques for Describing Alterations in Material Properties of Cartilage and Intervertebral Disc Tissue
Current Medical Imaging Mitochondrial Pathology in Osteoarthritic Chondrocytes
Current Drug Targets